Start here: pieces left behind
Persistent antigen is the idea that fragments of the virus, its spike and nucleocapsid proteins, can linger in tissue after the infection itself has resolved. Unlike a full viral reservoir, this is about leftover proteins rather than necessarily live virus, and those proteins may be biologically active on their own.
It matters because a protein does not need to be part of a replicating virus to cause trouble. If spike fragments persist and keep irritating tissue, that offers a route by which long COVID could continue long after any infection is over.
The well-founded link
The stronger of its two main connections is to endothelial dysfunction. Persistent spike protein driving injury to the vessel lining is graded moderate and audited as a well-founded mechanism, supported across more than one line of work.1
This gives persistent antigen a credible route to the vascular problems at the center of much long COVID biology: lingering spike, injured endothelium, downstream vascular symptoms. That chain rests on reasonably solid ground.
moderatewell-founded mechanismendothelial route
The link to watch
Its other main connection, to fibrinaloid microclots, is weaker and worth reading carefully. Spike protein can induce abnormal, amyloid-like fibrin in the test tube, but the replication of that finding sits largely within one research group's ecosystem, which is flagged as single-group amplification.2
That flag is not an accusation; it is a calibration. A claim repeated mainly by the group that originated it carries less independent weight than one confirmed across many labs. So the spike-to-microclot link should be held more tentatively than the spike-to-endothelium one, even though both appear in the same discussions.
low-moderatesingle-group amplificationin vitro
How this fits the persistence picture
Persistent antigen sits alongside the broader idea of a viral reservoir, and the two are related but not identical. A reservoir implies lingering or even replicating virus; persistent antigen is specifically about leftover viral proteins, which may remain biologically active even if no intact virus survives.
That distinction shapes how it might be treated. If the problem is leftover protein rather than ongoing replication, then antiviral drugs aimed at stopping the virus copying itself may matter less than approaches that clear or neutralise the antigen, such as antibodies. The trials in this space are partly an attempt to tell these possibilities apart.
For now, persistent antigen is best held as a serious, partly well-founded mechanism that helps explain how symptoms continue after infection, with its vascular route the most solid part. It is one of the reasons the reservoir-clearing treatments are being tested, even though none has yet shown benefit.
Why the distinction matters
Holding these two links at different strengths is the whole lesson of this page. Persistent antigen is a serious, credible mechanism, especially through its vascular route, and it is the rationale behind treatments aimed at clearing lingering virus or antigen.
But not every claim attached to it is equally supported. Learning to separate the well-founded endothelial link from the single-group microclot link is exactly the kind of discrimination that keeps a compelling mechanism from being oversold.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- How common persistent antigen is, and in which tissues it lingers.
- Whether the antigen is actively harmful or an inert leftover in some people.
- Whether the spike-to-microclot link holds up beyond the originating group.
- Whether clearing antigen, if achievable, changes symptoms.
- How persistent antigen relates to a full viral reservoir versus standing alone.
- How to detect lingering antigen reliably in living patients.
What this means for you
If you have read that leftover spike protein could be keeping you ill, there is a credible mechanism behind that idea, strongest through injury to the vessel lining. It gives a plausible route by which symptoms continue after the infection is over, and it underlies the trials aimed at clearing lingering virus or antigen.
Read the specific claims with care, though. The link from spike to endothelial injury is well-founded, while the link from spike to microclots rests heavily on a single research group and deserves more caution. That difference is worth carrying, because a compelling mechanism is easiest to oversell precisely where its evidence is thinnest.
Carry two things from this page. Persistent antigen is a credible mechanism for how symptoms continue after infection, strongest through its injury to the vessel lining, and it underlies the reservoir-clearing treatments now in trials. But weigh its specific claims separately, trusting the well-founded endothelial link more than the single-group microclot one, because that discrimination is exactly what keeps a compelling idea from being oversold. Held that way, the mechanism stays genuinely useful without hardening into a story that outruns its own evidence.
References
Each reference links to the source on PubMed, PMC, or the publisher.